Related Experiment Video
Updated: Mar 15, 2026

Author Spotlight: Unveiling the Role of TMOD3 in Platinum Resistance and Immune Infiltration in Ovarian Cancer
Published on: August 2, 2024
Matrix metalloproteinase-3 gene promoter polymorphisms: A potential risk factor for pelvic organ prolapse
Charalampos Karachalios1, Panagiotis Bakas1, Georgios Kaparos2
1Second Department of Obstetrics and Gynecology, Aretaieio University Hospital, National and Kapodistrian University of Athens, Medical School, Athens 11528, Greece.
Abstract:
Pelvic organ prolapse (POP) is a common multifactorial condition. Matrix metalloproteinases (MMPs) are enzymes capable of breaking down various connective tissue elements. Single-nucleotide polymorphisms (SNPs) in regulatory areas of MMP-encoding genes can alter their transcription rate, and therefore the possible effect on pelvic floor supporting structures. The insertion of an adenine (A) base in the promoter of the MMP-3 gene at position -1612/-1617 produces a sequence of six adenines (6A), whereas the other allele has five (5A). The aim of the present study was to investigate the possible association of MMP-3 gene promoter SNPs with the risk of POP. The patient group comprised 80 women with clinically significant POP [Stage II, III or IV; POP quantification (POP-Q) system]. The control group consisted of 80 females without any or important pelvic floor support defects (Stages 0 or I; POP-Q system). All the participants underwent the same preoperative evaluation. SNP detection was determined with whole blood sample DNA analysis by quantitative polymerase chain reaction (PCR) in LightCycler® PCR platforms, using the technique of sequence-specific hybridization probe-binding assays and melting temperature curve analysis. The results showed there was no statistically significant difference between 5A/5A, 5A/6A and 6A/6A MMP-3 gene promoter variants in the two study groups (P=0.4758). Therefore, MMP-3 gene promoter SNPs alone is insufficient to increase the genetic susceptibility to POP development.
Insights
Single-nucleotide polymorphisms (SNPs) in the MMP-3 gene promoter were investigated for their association with pelvic organ prolapse (POP). The study found no significant difference in MMP-3 gene promoter variants between women with and without POP, suggesting SNPs alone do not increase genetic susceptibility.
Area of Science:
- Genetics
- Biochemistry
- Gynecology
Background:
- Pelvic organ prolapse (POP) is a common condition affecting connective tissue integrity.
- Matrix metalloproteinases (MMPs) degrade connective tissues; their activity can be influenced by genetic variations.
- Single-nucleotide polymorphisms (SNPs) in MMP genes, such as MMP-3, may impact pelvic floor support.
Purpose of the Study:
- To investigate the association between MMP-3 gene promoter single-nucleotide polymorphisms (SNPs) and the risk of developing pelvic organ prolapse (POP).
Main Methods:
- Genotyping of MMP-3 gene promoter variants (5A/6A) using quantitative polymerase chain reaction (PCR) in 80 women with POP and 80 controls.
- Analysis of SNP detection via sequence-specific hybridization probe-binding assays and melting curve analysis.
Main Results:
- No statistically significant difference was observed in the distribution of MMP-3 gene promoter variants (5A/5A, 5A/6A, 6A/6A) between the POP patient group and the control group (P=0.4758).
Conclusions:
- MMP-3 gene promoter single-nucleotide polymorphisms (SNPs) alone are insufficient to confer increased genetic susceptibility to pelvic organ prolapse (POP).
- Further research may be needed to explore other genetic or environmental factors contributing to POP development.
More Related Videos
03:49Anogenital Distance and Perineal Measurements of the Pelvic Organ Prolapse POP Quantification System
Published on: September 20, 2018
07:41Quantification of Levator Ani Hiatus Enlargement by Magnetic Resonance Imaging in Males and Females with Pelvic Organ Prolapse
Published on: April 17, 2019
Related Concept Videos
Mitral Valve Prolapse III: Nursing Management
Role of Matrix Metalloproteases in Degradation of ECM
Abnormal Proliferation
Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu